Celemics

Celemics P/TBV

The Price to Tangible Book Value (P/TBV) of Celemics (331920.KQ) as of Nov 3, 2026 is 2.47. In the previous year, Price to Tangible Book Value (P/TBV) was 2.09 — a change of 17.89% (higher).

P/TBV

2.47

YoY

17.89%

Last updated:

Price to Tangible Book Value (P/TBV) of Celemics is 2025 2.47 . Price to Tangible Book Value (P/TBV) of Celemics was 2024 2.09 . It decreases by 17.89% higher compared to the previous year.

The Celemics P/TBV history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/TBV
Date
P/TBV
Jan 1, 2018
-1.87 KRW
Jan 1, 2019
11.53 KRW
Jan 1, 2020
1.95 KRW
Jan 1, 2021
2.45 KRW
Jan 1, 2022
3.08 KRW
Jan 1, 2023
3.60 KRW
Jan 1, 2024
2.09 KRW
Jan 1, 2025
2.47 KRW
The Celemics P/TBV history
YEARP/TBVYoY
2.47+17.89%
2.09-41.79%
3.60+16.84%
3.08+25.75%
2.45+25.51%
1.95-83.08%
11.53-718.23%
-1.87-64.13%
-5.20—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Celemics Stock analysis

What does Celemics do? Celemics Inc is a South Korean company based in Seoul, operating within the Health Care sector, specifically in the Life Sciences Tools & Services industry. The company provides biotechnology services, focusing on the development and sale of target capture kit products. It also offers immune repertoire analysis solutions and next-generation sequencing solutions. Celemics Inc went public through an IPO on August 21, 2020, and currently employs 63 full-time staff. The company's products are sold in both domestic and international markets. Its headquarters are located in Seoul, South Korea, and it maintains a website at www.celemics.com. The firm's primary business activities include the provision of specialized biotechnology services, with an emphasis on innovative tools and solutions for life science research and applications. Celemics Inc has a presence in the Korean market and extends its reach to global customers, supporting various research and diagnostic needs through its technology-driven services. The company's operational focus remains on developing and delivering advanced biotechnology solutions to meet the evolving demands of the life sciences industry. Celemics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Celemics stock

Price to Tangible Book Value (P/TBV) of Celemics is 2.47 in 2025.

Price to Tangible Book Value (P/TBV) of Celemics changed from 2.09 to 2.47, representing a 17.89% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Price to Tangible Book Value (P/TBV) Celemics since 2006 – with annual values, charts, and detailed analysis.

P/TBV compares the stock price to tangible book value per share, excluding goodwill and intangibles. It provides a conservative asset-based valuation.

To evaluate Price to Tangible Book Value (P/TBV)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Price to Tangible Book Value (P/TBV).

A 'good' varies by industry and company stage. On Eulerpool, you can compare Price to Tangible Book Value (P/TBV)'s Celemics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Celemics

All Key Metrics — Celemics